Consolidated Statement Of Cash Flows

Japan Tissue Engineering Co., Ltd. - Filing #7257092

Concept 2024-04-01 to
2025-03-31
As at
2025-03-31
As at
2024-03-31
2023-04-01 to
2024-03-31
As at
2023-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Profit (loss) before income taxes
-234,487,000 JPY
147,009,000 JPY
Depreciation
158,474,000 JPY
134,048,000 JPY
Increase (decrease) in provision for retirement benefits
4,725,000 JPY
JPY
Interest and dividend income
-2,612,000 JPY
-782,000 JPY
Increase (decrease) in provision for bonuses
-34,605,000 JPY
34,439,000 JPY
Decrease (increase) in trade receivables
14,458,000 JPY
-32,428,000 JPY
Subtotal
-122,742,000 JPY
277,219,000 JPY
Income taxes paid
-27,250,000 JPY
-3,770,000 JPY
Decrease (increase) in inventories
46,864,000 JPY
9,056,000 JPY
Net cash provided by (used in) operating activities
-148,365,000 JPY
274,138,000 JPY
Increase (decrease) in trade payables
25,693,000 JPY
-52,333,000 JPY
Other, net
-86,624,000 JPY
12,114,000 JPY
Interest and dividends received
1,627,000 JPY
689,000 JPY
Cash flows from investing activities
Payments into time deposits
-2,200,000,000 JPY
-2,200,000,000 JPY
Proceeds from withdrawal of time deposits
2,200,000,000 JPY
2,100,000,000 JPY
Purchase of property, plant and equipment
-76,119,000 JPY
-195,909,000 JPY
Purchase of investment securities
-150,000,000 JPY
JPY
Net cash provided by (used in) investing activities
-232,526,000 JPY
-242,230,000 JPY
Other, net
987,000 JPY
180,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-3,000 JPY
0 JPY
Net cash provided by (used in) financing activities
-3,000 JPY
-134,000 JPY
Repayments of lease liabilities
JPY
-133,000 JPY
Net increase (decrease) in cash and cash equivalents
-380,894,000 JPY
31,773,000 JPY
Cash and cash equivalents
1,685,449,000 JPY
2,066,344,000 JPY
2,034,570,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.